21.5% of assets are invested in small- and mid-cap pharmaceutical firms such as Mylan MYL, Salix SLXP, and Theravance THRX ; the U.S.' largest pharmaceutical firms trade on the New York Stock Exchange. IBB's index is one of eight
Retiree : Within a few weeks Theravance ( THRX ) will split into two distinct ..... all other programs the current Theravance is developing. Biopharma will ..... all, let's take a look at Theravance 's likely future. How much
By KL Investment Partners : Theravance ( THRX ) is a biopharmaceutical company focused on the discovery ..... under agreements with GSK, which will pay annual royalties to Theravance . Unless stated otherwise, information is from the 10-K
Theravance , Inc. ( THRX ) JKLM Conference Call March 11, 2014 10:15 AM ET Executives ..... pleased to have our next presenting biotech company which is Theravance . And Theravance has made a lot of progress recently in terms of regulatory
WASHINGTON, Sept 10 (Reuters) - An federal advisory panel has recommended that the U.S. Food and Drug Administration approve a drug made by GlaxoSmithKline Plc and Theravance Inc to treat chronic...
Sept 6 (Reuters) - An experimental drug to treat chronic obstructive pulmonary disease made by GlaxoSmithKline Plc and Theravance Inc appears to work, but its safety data are not entirely conclusive,...
proposed new business deals, and we're maintaining our fair value estimate as we digest the news in relation to last week's Theravance deal announcement. We're intrigued by Elan's decision to take a page out of Valeant's playbook, focusing on underpenetrated
Theravance THRX reported second-quarter earnings that matched our expectations, and we are keeping our fair value estimate at $29 per share
Elan ELN has announced that it intends to pay $1 billion to Theravance for a 21% stake in its royalty stream from partner GlaxoSmithKline ..... The deal relates to four of the six programs included in Theravance 's 2002 LABA partnership with Glaxo: Relvar Ellipta/Breo
* Drug will compete with AstraZeneca's Symbicort (Updates with FDA comment, side effects)